• Mashup Score: 0

    Direct-to-consumer testing, combined with clinical follow-up, helped identify patients with undiagnosed alpha-1 antitrypsin deficiency, according to data published in Chest. This autosomal co-dominant condition predisposes individuals to emphysema, as well as cirrhosis, panniculitis and vasculitis, according to the researchers.

    Tweet Tweets with this article
    • In combination with clinical follow-up, direct-to-consumer testing helps to identify undiagnosed patients with alpha-1 #antitrypsin #deficiency, researchers reported in @Journal_CHEST @23andMeResearch https://t.co/q8SFQEyaJ6

  • Mashup Score: 0

    Direct-to-consumer testing, combined with clinical follow-up, helped identify patients with undiagnosed alpha-1 antitrypsin deficiency, according to data published in Chest. This autosomal co-dominant condition predisposes individuals to emphysema, as well as cirrhosis, panniculitis and vasculitis, according to the researchers.

    Tweet Tweets with this article
    • In combination with clinical follow-up, direct-to-consumer testing helps to identify undiagnosed patients with alpha-1 #antitrypsin #deficiency, researchers reported in @Journal_CHEST @23andMeResearch https://t.co/NCUuM6CfIq

    • In combination with clinical follow-up, direct-to-consumer testing helps to identify undiagnosed patients with alpha-1 #antitrypsin #deficiency, researchers reported in @Journal_CHEST @23andMeResearch https://t.co/Q7aiO18RNf